Goldhirsch A - Search Results

1

Methotrexate/nitrous-oxide toxic interaction in perioperative chemotherapy for early breast cancer.

Goldhirsch A, Gelber RD, Tattersall MN, Rudenstam CM, Cavalli F. Goldhirsch A, et al. Lancet. 1987 Jul 18;2(8551):151. doi: 10.1016/s0140-6736(87)92345-2. Lancet. 1987. PMID: 2885607 Clinical Trial. No abstract available.

2

Tamoxifen therapy for patients with breast cancer.

Neven P, Joensuu H, Osborne K, Cardoso F, Loibl S, Linn S, Goldhirsch A, Ortmann O, Senn HJ, Hayes DF. Neven P, et al. Among authors: goldhirsch a. Lancet. 2013 Jun 15;381(9883):2078. doi: 10.1016/S0140-6736(13)61237-4. Lancet. 2013. PMID: 23769226 No abstract available.

3

Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?

Aebi S, Gelber S, Castiglione-Gertsch M, Gelber RD, Collins J, Thürlimann B, Rudenstam CM, Lindtner J, Crivellari D, Cortes-Funes H, Simoncini E, Werner ID, Coates AS, Goldhirsch A. Aebi S, et al. Among authors: goldhirsch a. Lancet. 2000 May 27;355(9218):1869-74. doi: 10.1016/s0140-6736(00)02292-3. Lancet. 2000. PMID: 10866443 Review.

4

Depression and degree of acceptance of adjuvant cytotoxic drugs.

Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A. Colleoni M, et al. Among authors: goldhirsch a. Lancet. 2000 Oct 14;356(9238):1326-7. doi: 10.1016/S0140-6736(00)02821-X. Lancet. 2000. PMID: 11073026

5

Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis.

Cole BF, Gelber RD, Gelber S, Coates AS, Goldhirsch A. Cole BF, et al. Among authors: goldhirsch a. Lancet. 2001 Jul 28;358(9278):277-86. doi: 10.1016/S0140-6736(01)05483-6. Lancet. 2001. PMID: 11498214 Review.

6

Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Clarke M, Coates AS, Darby SC, Davies C, Gelber RD, Godwin J, Goldhirsch A, Gray R, Peto R, Pritchard KI, Wood WC. Early Breast Cancer Trialists' Collaborative Group (EBCTCG), et al. Among authors: goldhirsch a. Lancet. 2008 Jan 5;371(9606):29-40. doi: 10.1016/S0140-6736(08)60069-0. Lancet. 2008. PMID: 18177773 Review.

7

Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group.

Cote RJ, Peterson HF, Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, Gusterson B, Neville AM. Cote RJ, et al. Among authors: goldhirsch a. Lancet. 1999 Sep 11;354(9182):896-900. doi: 10.1016/s0140-6736(98)11104-2. Lancet. 1999. PMID: 10489948 Clinical Trial.

8

Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil. International Breast Cancer Study Group.

Colleoni M, Price KN, Castiglione-Gertsch M, Gelber RD, Coates AS, Goldhirsch A. Colleoni M, et al. Among authors: goldhirsch a. Lancet. 1999 Jul 10;354(9173):130-1. doi: 10.1016/s0140-6736(99)02015-2. Lancet. 1999. PMID: 10408495 Clinical Trial.

9

Subsets within the chemotherapy overview. International Breast Cancer Study Group.

Coates AS, Gelber RD, Goldhirsch A. Coates AS, et al. Among authors: goldhirsch a. Lancet. 1998 Nov 28;352(9142):1783-4. doi: 10.1016/s0140-6736(05)79861-5. Lancet. 1998. PMID: 9848379 No abstract available.

10

Premenopausal oopherectomy versus CMF chemotherapy in stage II breast carcinoma. The International Breast Cancer Study Group (IBCSG).

Gelber RD, Goldhirsch A, Castiglione M, Rudenstram CM, Collins J, Senn HJ. Gelber RD, et al. Among authors: goldhirsch a. Lancet. 1993 Jul 31;342(8866):305. doi: 10.1016/0140-6736(93)91853-e. Lancet. 1993. PMID: 8101330 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results